These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 21924869)

  • 41. Crucial role of phospholipase Cepsilon in induction of local skin inflammatory reactions in the elicitation stage of allergic contact hypersensitivity.
    Hu L; Edamatsu H; Takenaka N; Ikuta S; Kataoka T
    J Immunol; 2010 Jan; 184(2):993-1002. PubMed ID: 20007527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor necrosis factor-alpha and ultraviolet B light have similar effects on contact hypersensitivity in mice.
    Yoshikawa T; Streilein JW
    Reg Immunol; 1990-1991; 3(3):139-44. PubMed ID: 2098069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mast cells down-regulate CD4+CD25+ T regulatory cell suppressor function via histamine H1 receptor interaction.
    Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW
    J Immunol; 2009 Sep; 183(5):3014-22. PubMed ID: 19667094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases.
    Reber L; Da Silva CA; Frossard N
    Eur J Pharmacol; 2006 Mar; 533(1-3):327-40. PubMed ID: 16483568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of the T suppressor circuit of delayed-type hypersensitivity by interferon.
    Knop J; Stremmer R; Taborski U; Freitag W; de Maeyer-Guignard J; Macher E
    J Immunol; 1984 Nov; 133(5):2412-6. PubMed ID: 6237149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AWD 12-281, a highly selective phosphodiesterase 4 inhibitor, is effective in the prevention and treatment of inflammatory reactions in a model of allergic dermatitis.
    Bäumer W; Gorr G; Hoppmann J; Ehinger AM; Rundfeldt C; Kietzmann M
    J Pharm Pharmacol; 2003 Aug; 55(8):1107-14. PubMed ID: 12956900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential modulation of contact hypersensitivity and delayed hypersensitivity reactions by topical application of 12-O-tetradecanoylphorbol-13-acetate.
    Kodari E; Pavone A; Reiners JJ
    Immunopharmacol Immunotoxicol; 1993 Nov; 15(5):639-47. PubMed ID: 8301022
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective role of palmitoylethanolamide in contact allergic dermatitis.
    Petrosino S; Cristino L; Karsak M; Gaffal E; Ueda N; Tüting T; Bisogno T; De Filippis D; D'Amico A; Saturnino C; Orlando P; Zimmer A; Iuvone T; Di Marzo V
    Allergy; 2010 Jun; 65(6):698-711. PubMed ID: 19909294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage.
    Scholzen TE; Steinhoff M; Sindrilaru A; Schwarz A; Bunnett NW; Luger TA; Armstrong CA; Ansel JC
    FASEB J; 2004 Jun; 18(9):1007-9. PubMed ID: 15084523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of etoposide on allergic contact dermatitis induced by dinitrofluorobenzene and its action mechanism in mice].
    Xie Q; Yan HL; Li YQ; Wang J; Wang JY
    Yao Xue Xue Bao; 2007 Oct; 42(10):1050-3. PubMed ID: 18229610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stress-induced modulation of skin immune function: two types of antigen-presenting cells in the epidermis are differentially regulated by chronic stress.
    Nakano Y
    Br J Dermatol; 2004 Jul; 151(1):50-64. PubMed ID: 15270872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suppressor T cell circuits in contact sensitivity. II. Induction and characterization of an efferent-acting, antigen-specific, H-2-restricted, monoclonal T cell hybrid-derived suppressor factor specific for DNFB contact hypersensitivity.
    Miller SD
    J Immunol; 1984 Dec; 133(6):3112-20. PubMed ID: 6208271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extended DNFB-induced contact hypersensitivity models display characteristics of chronic inflammatory dermatoses.
    Röse L; Schneider C; Stock C; Zollner TM; Döcke WD
    Exp Dermatol; 2012 Jan; 21(1):25-31. PubMed ID: 22151387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence-based treatment options for the management of skin toxicities associated with epidermal growth factor receptor inhibitors.
    Tan EH; Chan A
    Ann Pharmacother; 2009 Oct; 43(10):1658-66. PubMed ID: 19755624
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immediate contact hypersensitivity induced by repeated hapten challenge in mice.
    Natsuaki M; Yano N; Yamaya K; Kitano Y
    Contact Dermatitis; 2000 Nov; 43(5):267-72. PubMed ID: 11016667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis.
    Terakawa M; Fujieda Y; Tomimori Y; Muto T; Tanaka T; Maruoka H; Nagahira K; Ogata A; Nakatsuka T; Fukuda Y
    Eur J Pharmacol; 2008 Dec; 601(1-3):186-91. PubMed ID: 18996112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuropeptide denervation alters both the elicitation and induction phases of contact hypersensitivity in mice.
    Veronesi B; Williams WC; Smialowicz RJ; Sailstad DM; Doerfler D; Selgrade MJ
    Toxicol Appl Pharmacol; 1998 Dec; 153(2):243-9. PubMed ID: 9878594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histone deacetylases inhibitor Trichostatin A ameliorates DNFB-induced allergic contact dermatitis and reduces epidermal Langerhans cells in mice.
    Shi YL; Gu J; Park JJ; Xu YP; Yu FS; Zhou L; Mi QS
    J Dermatol Sci; 2012 Nov; 68(2):99-107. PubMed ID: 22999682
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A critical role for dermal mast cells in cis-urocanic acid-induced systemic suppression of contact hypersensitivity responses in mice.
    Hart PH; Grimbaldeston MA; Swift GJ; Hosszu EK; Finlay-Jones JJ
    Photochem Photobiol; 1999 Nov; 70(5):807-12. PubMed ID: 10568173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The putative lipid raft modulator miltefosine displays immunomodulatory action in T-cell dependent dermal inflammation models.
    Bäumer W; Wlaź P; Jennings G; Rundfeldt C
    Eur J Pharmacol; 2010 Feb; 628(1-3):226-32. PubMed ID: 19917276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.